First-Episode Psychosis and Co-Occurring Substance Use Disorders
$10.00 | CE Hours:2.00 | Beginning
CE Course Description
The transition to adulthood can be especially challenging for young people who experience an emerging serious mental illness such as first-episode psychosis and who have a co-occurring substance use condition, and research shows that implementing evidence-based practices requires a comprehensive, multi-pronged approach. This CE course reviews the scientific literature, examines emerging and best practices, determines key components of peer-reviewed models, and identifies challenges and gaps in implementation.
Author: Substance Abuse and Mental Health Services Administration: First-Episode Psychosis and Co-Occurring Substance Use Disorders. Publication No. PEP19-PL-Guide-3 Rockville, MD: National Mental Health and Substance Use Policy Laboratory. Substance Abuse and Mental Health Services Administration, 2019.
References / Contributions by:
Substance Abuse and Mental Health Services Administration. (2013). Results from the 2012 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration.
Kane, J. M., Robinson, D. G., Schooler, N. R., Mueser, K.T., Penn, D.L., Rosenheck, R. A., Heinssen, R. (2016). Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. American Journal of Psychiatry, 173, 362- 372.
Ford, E. (2015). First-episode psychosis in the criminal justice system: identifying a critical intercept for early intervention. Harvard Review of Psychiatry, 23(3), 167-175.
Retrieved from: https://store.samhsa.gov/product/First-Episode-Psychosis-and-Co-Occurring-Substance-Use-Disorders/PEP19-PL-Guide-3
CE Course Objectives
1. Conclude which medication was found to be superior to other antipsychotics in terms of reducing substance use.
2. Describe the first task to creating a program culture that supports treatment for substance misuse / disorders within first-episode psychosis services.
3. Differentiate between substance misuse and a substance use disorder.
4. Identify which substance is associated with cardiometabolic problems among young adults with first-episode psychosis.
5. Name five symptoms of psychosis.
6. Provide three features that are usually part of generalized treatment for first-episode psychosis.
CE Outline with Main Points
1. Evidence-Based Resource Guide Series Overview
2. First-Episode Psychosis and Co-Occurring Substance Use Disorders
b. What is First-Episode Psychosis?
c. Disorders in Which Psychosis May Occur
d. What are Substance Misuse and Substance Use Disorders?
e. First-Episode Psychosis and Co-Occurring Substance Misuse or Substance Use Disorders
f. Coordinated Specialty Care
g. Integration of Treatment Approaches for Substance Misuse and Substance Use Disorders in the Context of Treatment for First-Episode Psychosis
h. Coordinated Specialty Care in Rural Settings
i. Challenges of Addressing Substance Use Disorders in the Context of First-Episode Psychosis
3. Effectiveness of Treatment for Substance Use Disorders Among Persons with First-Episode Psychosis
a. Changes in Substance Use in Response to Generalized Treatment for First-Episode Psychosis
b. Effectiveness of Targeted Interventions on Substance Use Outcomes
c. Controlled Trials of Targeted Interventions on Functional Outcomes
d. Using the Evidence to Guide Practice
4. Evidence-Based Programs for Implementing Integrated Treatment of Substance Use Disorders and First-Episode Psychosis
a. Choosing Programs
b. Model #1: The Early Assessment and Support Alliance (EASA)
c. Model #2: Early Diagnosis and Preventive Treatment (EDAPT)
d. Model #3: Portland Identification and Early Referral (PIER) Program
5. Guidance for Implementing Evidence-Based Practices
a. Implementation Strategies and Tasks
b. Common Implementation Barriers and Ways to Address Them
6. Resources for Implementation, Evaluation, and Quality Improvement
a. Screening and Assessment
b. Service Delivery Guides
c. Coordinated Specialty Care Implementation
d. Informational Resources for Young Adults and Families
Social Work Approval
Social Work CE Credit for this course is offered with the following approvals. Many state boards of social work will accept the approvals listed. Provider Approvals by state and license type can be found here.
- Quantum Units Education is approved by the California Association of Marriage and Family Therapists, CAMFT Provider #89970, to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEP. Quantum Units Education maintains responsibility for this program/course and its content.
- Florida board for Social Workers CE Provider #50-8650 (Quantum 'immediately' reports CE Credits to Florida licensees)
- Illinois Department of Professional Regulation, License No. 159.001261 approved CE Sponsor
- Ohio CSWMFTB #RCST091701 approved CE Provider
- Texas Board of SWE #5070 approved CE Provider
- Quantum Units Education, #1289, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 01/03/2020 - 01/03/2023. Social workers completing this course receive 2.00 'Clinical' continuing education credits.
To see other approvals in your state, see our state by state provider approval listings here.
This course is CAADE approved.
Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degrees of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.
Added On: 2020-01-06